Indications and uses
Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • itchy nose • runny nose • itchy, watery eyes • sneezing
Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • itchy nose • runny nose • itchy, watery eyes • sneezing
• read the Quick Start Guide for how to: o prime the bottle o use the spray o clean the spray nozzle • shake gently before each use • use this product only once a day • do not use more than directed ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER • Week 1- use 2 sprays in each nostril once daily • Week 2 through 6 months- use 1 or 2 sprays in each nostril once daily, as needed to treat your symptoms • After 6 months...
• you may start to feel relief the first day and full effect after several days of regular, once-a-day use • store between 4° and 30°C (39° and 86°F) • keep this label and enclosed materials. They contain important additional information.
Fluticasone propionate (glucocorticoid)* 50 mcg
*read the Question & Answer Leaflet
Allergy symptom reliever
Temporarily relieves these symptoms of hay fever or other upper respiratory allergies:
Only for use in the nose. Do not spray into your eyes or mouth.
have or had glaucoma or cataracts
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER
CHILDREN 4 TO 11 YEARS OF AGE
CHILDREN UNDER 4 YEARS OF AGE
benzalkonium chloride, dextrose, microcrystalline cellulose, phenylethylalcohol, polysorbate 80, purified water, sodium carboxymethylcellulose
call toll-free 1-844-FLONASE (1-844-356-6273)
What problems can FLONASE Allergy Relief help with?
FLONASE Allergy Relief helps relieve a broad range of uncomfortable symptoms like congestion and itchy eyes.
Nasal symptoms
Eye symptoms
These symptoms can be triggered by allergens like pollen, mold, dust or pet dander.
Outdoor allergens
Animal allergens
Indoor allergens
IMPORTANT – Peel here for complete Drug Facts label. Children 4-11: do not use for more than 2 months a year.
Be sure to read the Quick Start Guide and Question & Answer Leaflet inside package
TAMPER-EVIDENTfeatures for your protection. The product is packaged in a sealed container. Under the cap and nozzle, each bottle has an aluminum seal around bottle neck. Do not use if any of these features are torn or damaged.
FLONASE
ALLERGY RELIEF
Fluticasone Propionate Nasal Spray 50 mcg Per Spray Allergy Symptom Reliever (Glucocorticoid)*
Non-Drowsy Relief of:
FULL PRESCRIPTION STRENGTH
24 HOUR RELIEF
0.62 fl oz (18.2 mL)
144 METERED SPRAYS
*Fluticasone propionate is a steroid medicine known as a glucocorticoid.

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1797933 | FLONASE 50 MCG/ACTUAT Metered Dose Nasal Spray | PSN | 21 |
| 1797907 | fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray | PSN | 21 |
| 1797933 | fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Flonase] | SBD | 21 |
| 1797907 | fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray | SCD | 21 |
| 1797933 | Flonase 0.05 MG/ACTUAT Metered Dose Nasal Spray | SY | 21 |
| 1797933 | Flonase 50 MCG/ACTUAT Metered Dose Nasal Spray | SY | 21 |
| 1797907 | fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray | SY | 21 |
| Class | Version | Type | Effective |
|---|---|---|---|
| FLUTICASONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f4fb2f5a-dadb-40e3-a4b1-a2a58f5d9a33 | Product name | 3 | 20260126 |
| 343e8617-eb68-1e10-cfa9-8c30af285764 | Product name | 3 | 20240513 |
| a31ad3df-8021-2ea1-94eb-0fe2f49b7729 | Product name | 4 | 20220719 |
| 813fe018-3e3c-40e4-8f71-7ab50f3dfe81 | Product name | 2 | 20180723 |
| 3bcd721e-0555-4bc3-96c6-690471ff9d94 | Product name | 1 | 20171113 |
| 9f9452df-fa34-43d4-97fe-c6605344c5a8 | Product name | 1 | 20171113 |
| 0e5a25a6-9f05-44b5-8449-aa63e59f7202 | Product name | 1 | 20170426 |
| f3c5232f-03de-44f5-996a-90cd9c08bc60 | Product name | 1 | 20170426 |
| 1cb17fbb-0da4-2841-37bc-e7079783e1a2 | Product name | 1 | 20140508 |
| 667f427a-8698-a508-767a-53ed61b4c2e9 | Product name | 1 | 20140508 |
| 6a97ffc8-1d4d-a971-4978-85ba3a22eac9 | Product name | 1 | 20140508 |
| 6df84e13-2223-fa46-1e26-17e2f58a1e1c | Product name | 1 | 20140508 |
| 90fec588-984c-4375-cfd4-7e40114bdf80 | Product name | 1 | 20140508 |
| 9c1d3c48-b162-204b-f55b-e0f25c31c52e | Product name | 1 | 20140508 |
| 9fdb6139-394b-1510-4baf-bde68c419789 | Product name | 1 | 20140508 |
| aef26912-037b-9a4e-db49-225ef6dfd8f1 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0135-0576-01 | FLONASEALLERGY RELIEF | 1 in 1 CARTON | SPRAY, METERED | 1 | 21 | |
| 0135-0576-01 | FLONASEALLERGY RELIEF | 30 in 1 BOTTLE | SPRAY, METERED | 30 | 21 | |
| 0135-0576-02 | FLONASEALLERGY RELIEF | 60 in 1 BOTTLE | SPRAY, METERED | 60 | 21 | |
| 0135-0576-02 | FLONASEALLERGY RELIEF | 1 in 1 PACKAGE | SPRAY, METERED | 1 | 21 | |
| 0135-0576-03 | FLONASEALLERGY RELIEF | 1 in 1 PACKAGE | SPRAY, METERED | 1 | 21 | |
| 0135-0576-03 | FLONASEALLERGY RELIEF | 120 in 1 BOTTLE | SPRAY, METERED | 120 | 21 | |
| 0135-0576-04 | FLONASEALLERGY RELIEF | 3 in 1 PACKAGE | SPRAY, METERED | 3 | 21 | |
| 0135-0576-04 | FLONASEALLERGY RELIEF | 120 in 1 BOTTLE | SPRAY, METERED | 120 | 21 | |
| 0135-0576-12 | FLONASEALLERGY RELIEF | 120 in 1 BOTTLE | SPRAY, METERED | 120 | 21 | |
| 0135-0576-12 | FLONASEALLERGY RELIEF | 2 in 1 PACKAGE | SPRAY, METERED | 2 | 21 | |
| 0135-0576-14 | FLONASEALLERGY RELIEF | 1 in 1 PACKAGE | SPRAY, METERED | 1 | 21 | |
| 0135-0576-14 | FLONASEALLERGY RELIEF | 144 in 1 BOTTLE | SPRAY, METERED | 144 | 21 | |
| 0135-0576-15 | FLONASEALLERGY RELIEF | 2 in 1 PACKAGE | SPRAY, METERED | 2 | 21 | |
| 0135-0576-15 | FLONASEALLERGY RELIEF | 144 in 1 BOTTLE | SPRAY, METERED | 144 | 21 | |
| 0135-0576-16 | FLONASEALLERGY RELIEF | 144 in 1 BOTTLE | SPRAY, METERED | 144 | 21 | |
| 0135-0576-16 | FLONASEALLERGY RELIEF | 3 in 1 PACKAGE | SPRAY, METERED | 3 | 21 | |
| 0135-0576-17 | FLONASEALLERGY RELIEF | 1 in 1 PACKAGE | SPRAY, METERED | 1 | 21 | |
| 0135-0576-17 | FLONASEALLERGY RELIEF | 72 in 1 BOTTLE | SPRAY, METERED | 72 | 21 | |
| 0135-0576-18 | FLONASEALLERGY RELIEF | 90 in 1 BOTTLE | SPRAY, METERED | 90 | 21 | |
| 0135-0576-18 | FLONASEALLERGY RELIEF | 1 in 1 PACKAGE | SPRAY, METERED | 1 | 21 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0135-0576-02 | ML - Milliliter | 0135-0576 | 530d5343-ecd6-4d4c-8c91-009427e86b7d | 1 | 2015-02-02 |
| 0135-0576-03 | ML - Milliliter | 0135-0576 | 865c93a8-8bed-4d15-9ec7-6d112b4d31e7 | 1 | 2015-02-02 |
| 0135-0576-04 | ML - Milliliter | 0135-0576 | d0a68cc5-b3ef-40cb-98e4-287b6f5a3b0f | 1 | 2015-02-02 |
| 0135-0576-14 | ML - Milliliter | 0135-0576 | dd0b22db-120a-4750-9412-a0b7f66f9ffb | 1 | 2018-08-13 |
| 0135-0576-15 | ML - Milliliter | 0135-0576 | 5048df9c-fbbf-4899-880b-a2954d70f8bf | 1 | 2018-03-08 |
| 0135-0576-16 | ML - Milliliter | 0135-0576 | f5dd4265-38d2-4dc4-9d1c-e8e9a95a69df | 1 | 2018-03-08 |
| 0135-0576-17 | ML - Milliliter | 0135-0576 | cc1b971f-e7c4-4473-adcd-85d87f59cef7 | 1 | 2020-04-20 |
| 0135-0576-18 | ML - Milliliter | 0135-0576 | 2b27c673-6c75-4a9c-babe-637772aafa20 | 1 | 2025-09-12 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| FLUTICASONE PROPIONATE | ACTIVE INGREDIENT | O2GMZ0LF5W | 6 | |
| FLUTICASONE | ACTIVE MOIETY | CUT2W21N7U | 6 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 6 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | 6 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 6 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | 6 | |
| PHENYLETHYL ALCOHOL | INACTIVE INGREDIENT | ML9LGA7468 | 6 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0135-0576 | 0135-0576-01, 0135-0576-02, 0135-0576-03, 0135-0576-04, 0135-0576-12, 0135-0576-14, 0135-0576-15, 0135-0576-16, 0135-0576-17, 0135-0576-18 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FLUTICASONE PROPIONATE | O2GMZ0LF5W | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| DEXTROSE, UNSPECIFIED FORM | IY9XDZ35W2 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| PHENYLETHYL ALCOHOL | ML9LGA7468 | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| WATER | 059QF0KO0R | IACT |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED | K679OBS311 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SUSPENSION / ORAL | 560 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY, METERED / NASAL | 1 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET / ORAL | 280 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION / INTRAMUSCULAR | 30 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | SPRAY, METERED / NASAL | 50 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SOLUTION / ORAL | 161 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CREAM / VAGINAL | 0.75 %w/w | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 100 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / INTRAVITREAL | 0.5 %w/v | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / INTRAMUSCULAR | 30 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | GRANULE, FOR SUSPENSION / ORAL | 15.63 mg/5ml | ||
| PHENYLETHYL ALCOHOL | PHENYLETHYL ALCOHOL | ML9LGA7468 | SPRAY, METERED / NASAL | 2 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / INTRAVITREAL | 0.5 %w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / INTRAMUSCULAR | 30 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, DELAYED RELEASE / ORAL | 280 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION / INTRAMUSCULAR | 30 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SOLUTION / ORAL | 161 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SUSPENSION/ DROPS / ORAL | 12.85 mg/2.5ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, EXTENDED RELEASE / ORAL | 933 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | SPRAY, METERED / NASAL | 50 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SUSPENSION/ DROPS / ORAL | 12.85 mg/2.5ml | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / INTRAVITREAL | 0.5 %w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SYRUP / ORAL | 26.5 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, FILM COATED / ORAL | 50 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE, EXTENDED RELEASE / ORAL | 4 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / OPHTHALMIC | 1 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION / INTRA-ARTICULAR | 25 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SYSTEM / TOPICAL | 1680 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | AEROSOL, FOAM / VAGINAL | 0.2 %w/w | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / ORAL | 3480 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / ORAL | 3480 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | GEL / DENTAL | 0.4 %w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | PASTE / DENTAL | 249 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE, EXTENDED RELEASE / ORAL | 4 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, CHEWABLE / ORAL | 24.75 mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | AEROSOL, FOAM / VAGINAL | 0.2 %w/w |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N205434-001 | FLONASE ALLERGY RELIEF | FLUTICASONE PROPIONATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD, RS | 2014-07-23 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N205434-001 | FLONASE ALLERGY RELIEF | 0.05MG/SPRAY | SPRAY, METERED / NASAL | RLD | 2014-07-23 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FLONASE ALLERGY RELIEF | FLUTICASONE PROPIONATE | Haleon US Holdings LLC | b6134ba0-b70a-4eac-9a82-cef64b242c1d | 2024-12-19 | Warnings | 0135-0576-01 0135-0576-04 0135-0576-02 0135-0576-17 0135-0576-18 0135-0576-14 0135-0576-16 0135-0576-15 0135-0576-12 0135-0576-03 0135-0576 00135057603 00135057601 00135057616 00135057618 00135057604 00135057615 00135057617 00135057612 00135057614 00135057602 fe356980-6a1c-4830-b69c-7adb271b2e20 b6134ba0-b70a-4eac-9a82-cef64b242c1d |
Adverse event summaries are temporarily unavailable. Other product information remains available.